Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 2/20 | 0.60 |
| ▸ | CCKBR | P32239 | 3/20 | 0.58 |
| ▸ | NPY1R | P25929 | 3/20 | 0.56 |
| ▸ | NPY2R | P49146 | 3/20 | 0.56 |
| ▸ | NPY4R | P50391 | 3/20 | 0.56 |
| ▸ | GHSR | Q92847 | 5/20 | 0.55 |
| ▸ | GRPR | P30550 | 1/20 | 0.55 |
| ▸ | CCKAR | P32238 | 1/20 | 0.52 |
| ▸ | MC4R | P32245 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519296 | 1.00 | KISS1R (0.60) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL30494060 | 0.97 | KISS1R (0.60) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL29849030 | 0.95 | NPY1R (0.57) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL30618455 | 0.95 | NPY1R (0.57) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL29519677 | 0.92 | KISS1R (0.57) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL29399016 | 0.85 | GHSR (0.68) | KISS1RNPY1RNPY2RNPY4RGHSR | |
| SCHEMBL29402231 | 0.84 | GHSR (0.69) | KISS1RNPY1RNPY2RNPY4RGHSR | |
| SCHEMBL29357687 | 0.84 | KISS1R (0.62) | KISS1RMC4R | |
| SCHEMBL29559198 | 0.83 | NPY1R (0.65) | KISS1RCCKBRNPY1RNPY2RNPY4R | |
| SCHEMBL31332219 | 0.80 | CCKBR (0.55) | KISS1RCCKBRCCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2025-04-24 | — | — | US | disclosed |
| EP-4404912-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | Ferring B.V. (NL) | 2024-07-31 | — | — | EP | disclosed |
| WO-2023046336-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | FERRING B.V. (NL) | 2023-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250127843-A1 | ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE | MC2R, CRH, NR5A1 | KISS1R 254/4885CCKBR 672/4885NPY1R 64/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.